The hypothalamic-pituitary response in SLE. Regulation of prolactin,growth hormone and cortisol release

Abstract

It has been suggested that neuroendocrine regulation plays an important role in the pathogenesis and activation of autoimmune diseases. The aim of this investigation was to clarify the hypothalamic-pituitary response to a well-defined stimulus under standardised conditions in patients with SLE. Plasma concentrations of prolactin (PRL), growth hormone (GH) and cortisol were determined in venous blood drawn through an indwelling cannula during insulin-induced hypoglycaemia (0.1 U/kg b.w., i.v.) in ten patients and in 12 age-, gender-and weight-matched healthy subjects. Basal PRL concentrations were higher in patients vs healthy controls (12 vs 6ng/ml, P < 0.01), though still within the physiological range. Insulin-induced plasma PRL and GH were significantly increased both in patients and healthy subjects; however, the increments or areas under the curves were not different in the two groups. Plasma cortisol response showed moderate attenuation in patients. Sensitivity of pituitary lactotrothrops to thyrotropin-releasing hormone (TRH) administration (200 mg, i.v.) was the same in patients and control subjects. In SLE patients with low activity of the disease the sensitivity of pituitary PRL release to TRH administration remained unchanged. The hypothalamic response to stress stimulus (hypoglycaemia) was comparable in patients and healthy subjects.

Keywords

systemic lupus erythematosus (SLE)prolactin (PRL)TRH test hypoglycaemia stress

Get full access to this article

View all access options for this article.

References

Picco P et al. Prolactin and interleukin-6 in prepubertal girls with juvenile chronic arthritis . J. Rheumatol 1998; 25: 347-351 .

Tan EM et al. The revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

Ježová D , Vigaŝ M . Apomorphine injection stimulates beta-endorphin, adrenocorticotropin, and cortisol release in healthy man . Psychoneuroendocrinology 1988; 13: 479-485 .

Joubert-Bression D . Régulation de la sécretion de la prolactine. In: Fossati P (ed) La prolactine. Sandoz-Behring: Paris , 1991, 15-38.

Ježová D , Kvetnánský R , Vigaŝ M . Sex differences in endocrine response to hyperthermia in sauna . Acta Physiol Scand 1994; 150: 293-298 .

Noel GL , Suh HK , Stone JG , Franz AG . Human prolactin in survey and other conditions of stress . J Clin Endocr Metab 1972; 36: 840-851 .

Vigaŝ M . Problems of definition of stress stimulus and specificity of stress response. In: Usdin E , Kvetnánský R , Axelrod J (eds) Stress: The Role of Catecholamines and Other Neurotransmitters. Gordon and Breach Science Publishers: New York , 1984; 27-35.

Carlson HE , Wasser HL , Levin SR , Wilkins JN . Prolactin stimulation by meals is related to protein content . J Clin Endocrinol Metab 1982; 57: 334-338 .

Jara LJ , Lavalle C , Espinoza LR.

Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?

J Rheumatol 1992; 19: 1333-1336 .

10.

Masi AT , Da Silva JAP , Cutolo M . Pertubations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis . In: Chikanza IC (ed) Bailliere's Clinical Rheumatology. Neuroendocrine Immune Mechanisms of Rheumatic Diseases 1996; 10: 295-332 .

11.

Fox RA , Moore PM , Isenberg D . Neuroendocrine changes in systemic lupus erythematosus and Sjögren's syndrome . In: Chikanza IC (ed) Bailliere's Clinical Rheumatology. Neuroendocrine Immune Mechanisms of Rheumatic Diseases 1996; 10: 333-348 .

12.

Allen SH et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease . Lupus 1996; 5: 30-37 .

13.

Neidhart M . Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases . J Rheumatol 1996; 23: 476-481 .

14.

Kasnic TA , Wallerstedt CL , Gilson GJ . Systemic lupus erythematosus in pregnancy . J Prinat Neonata Nurs 1997; 11: 46-56 .

15.

Vigaŝ M et al. Glucoreceptors located in different areas mediate the hypoglycemia-induced release of growth hormone, prolactin and adrenocorticotropin in man . Neuroendocrinology 1990; 51: 365-368 .

16.

Chiodera P et al. Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier . Neuroendocrinology 1992; 55(6): 655-659 .

17.

Tsigos C et al. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure . Neuroendocrinology 1997; 66: 54-62 .

18.

Curti BD et al. Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer . J Immunothr Emphasis Tumor 1996; 19: 142-148 .

19.

McCann et al. Induction by cytokines of the pattern of pituitary hormone secretion in infection . Neuroimmodulation 1994; 1: 2-13 .

20.

Rovenský J et al. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 2330-2334 .

21.

Gutiérrez MA et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity . Lupus 1995; 4: 348-352 .

22.

Larrea F et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus . J Clin Endocrinol Metab 1997; 82: 3664-3669 .